You just read:

Levo Therapeutics to License Exclusive Rights to Ferring Pharmaceuticals' Orphan-Designated Drug, Carbetocin, for the Treatment of Prader-Willi Syndrome

News provided by

Levo Therapeutics, Inc.

Oct 27, 2016, 13:47 ET